← Open Payments lookup

STEPHEN SMITH: Open Payments

NPI 1174707368 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$853 in 39 payments from 8 companies in 2025. Trend: 2023 $272 · 2024 $890 · 2025 $853

Food & beverage: $853
CompanyPaymentsAmount
Alkermes, Inc.9$218
Teva Pharmaceuticals USA, Inc.7$150
Otsuka America Pharmaceutical, Inc.8$141
Lundbeck LLC6$132
Neurocrine BioSciences, Inc.4$97
ABBVIE INC.2$49
Janssen Pharmaceuticals, Inc2$44
E.R. Squibb & Sons, L.L.C.1$20

Products named: ARISTADA, ABILIFY ASIMTUFII, ABILIFY MAINTENA, INGREZZA, UZEDY, AUSTEDO XR, VRAYLAR, INVEGA SUSTENNA.

Industry payments across MS — which companies pay providers there.